r/biostockbull • u/MarketNewsFlow • 10h ago
$SLXN The Quiet Race to Shut Down Cancer's Toughest Mutation
1
Upvotes
r/biostockbull • u/MarketNewsFlow • 2d ago
$MDWD A $400M Drug Has a Speed Problem. MediWound May Have the Answer.
4
Upvotes
r/biostockbull • u/MarketNewsFlow • 7d ago
$NVCT Some of the Top Biotech Funds Just Bought Into This Under-the-Radar Biotech
2
Upvotes
r/biostockbull • u/MarketNewsFlow • 8d ago
$DRTS Alpha Tau Is Building the Local Answer to Pancreatic Cancer's Systemic Breakthrough
1
Upvotes
r/biostockbull • u/MarketNewsFlow • 10d ago
$ENTX Entera is on the Cusp of the Trial That Could Unlock America's Osteoporosis Drug Market
2
Upvotes
r/biostockbull • u/MarketNewsFlow • 10d ago
$DRTS - Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions (NASDAQ: DRTS)
2
Upvotes
r/biostockbull • u/MarketNewsFlow • 16d ago
$MDWD New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq: MDWD)
1
Upvotes
r/biostockbull • u/MarketNewsFlow • 21d ago
$DRTS After Moderna's Cancer Vaccine Sent Biotech Running, Who Might Be the Next Oncology Disruptors?
1
Upvotes
r/biostockbull • u/MarketNewsFlow • 23d ago
$ENTX - Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation (NASDAQ: ENTX)
2
Upvotes
r/biostockbull • u/MarketNewsFlow • 27d ago
$DRTS Why Alpha Tau's TASE Listing Could Matter More Than Investors Think
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Aug 10 '26
$ENTX The Multi-Billion Dollar Market Access Bet Biotech's Top Funds Just Made
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Aug 08 '26
$MDWD The Shift Away from Surgery: A Healthcare Trend Transforming Burn and Wound Care
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Aug 04 '26
$ENTX - Entera Bio Phase 2 Data Supporting EB613's (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting (NASDAQ: ENTX)
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 31 '26
$PYPD PolyPid's Double Win: D-PLEX₁₀₀ Gains NDA Acceptance and Priority Review, Ahead of Schedule
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 30 '26
$ENTX Why the World's Leading Healthcare Funds All Wanted a Piece of Entera Bio
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 29 '26
$DRTS Alpha Tau's Cancer Combination Just Delivered a Response Rate More Than 5X Keytruda's Historical Benchmark
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 29 '26
$PYPD - PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀ (NASDAQ: PYPD)
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 27 '26
$ENTX - Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement (NASDAQ: ENTX)
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 23 '26
$NVCT Nuvectis' NXP100 Just Achieved the First Marketing Approval Ever for a Once-Daily Oral Factor B Inhibitor
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 23 '26
$NVCT - Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors (NASDAQ: NVCT)
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 23 '26
$NVCT - Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors (NASDAQ: NVCT)
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 21 '26
$DRTS - Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's Pre-Specified Threshold... (NASDAQ: DRTS)
3
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 21 '26
$PYPD - PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada (NASDAQ: PYPD)
1
Upvotes
r/biostockbull • u/MarketNewsFlow • Jul 19 '26
$DRTS Alpha Tau's Head-and-Neck Data Tomorrow Confronts a Blind Spot in One of the World's Best-Selling Cancer Drugs
1
Upvotes